Inj iron dextran
Products billed under this code include Infed.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Infed.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Infed | Allergan, Inc. | 00023-6082-10 | 20 | $380.10 |
| Infed | Henry Schein Inc. | 00404-9879-02 | 2 | $38.01 |
| Infed | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1441-01 | 2 | $38.01 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $19.005 | +$0.012 | 50 MG | Inj iron dextran | v1, posted September 17, 2026 |
| 3Q26 | $18.993 | +$0.888 | 50 MG | Inj iron dextran | v1, posted September 15, 2026 |
| 2Q26 | $18.105 | +$0.024 | 50 MG | Inj iron dextran | v1, posted September 15, 2026 |
| 1Q26 | $18.081 | −$0.025 | 50 MG | Inj iron dextran | v1, posted September 15, 2026 |
| 4Q25 | $18.106 | +$0.08 | 50 MG | Inj iron dextran | v1, posted September 8, 2026 |
| 3Q25 | $18.026 | +$0.793 | 50 MG | Inj iron dextran | v1, posted March 10, 2026 |
| 2Q25 | $17.233 | −$0.171 | 50 MG | Inj iron dextran | v1, posted March 10, 2026 |
| 1Q25 | $17.404 | −$0.265 | 50 MG | Inj iron dextran | v1, posted December 19, 2025 |
| 4Q24 | $17.669 | −$0.321 | 50 MG | Inj iron dextran | v1, posted June 11, 2025 |
| 3Q24 | $17.99 | +$0.676 | 50 MG | Inj iron dextran | v1, posted June 11, 2025 |
| 2Q24 | $17.314 | −$0.01 | 50 MG | Inj iron dextran | v1, posted March 11, 2025 |
| 1Q24 | $17.324 | −$0.083 | 50 MG | Inj iron dextran | v1, posted December 19, 2024 |
| 4Q23 | $17.407 | +$0.231 | 50 MG | Inj iron dextran | v1, posted October 10, 2024 |
| 3Q23 | $17.176 | +$0.603 | 50 MG | Inj iron dextran | v1, posted June 5, 2024 |
| 2Q23 | $16.573 | −$0.006 | 50 MG | Inj iron dextran | v1, posted February 23, 2024 |
| 1Q23 | $16.579 | +$0.054 | 50 MG | Inj iron dextran | v1, posted December 6, 2023 |
| 4Q22 | $16.525 | +$0.152 | 50 MG | Inj iron dextran | v1, posted June 22, 2023 |
| 3Q22 | $16.373 | +$0.606 | 50 MG | Inj iron dextran | v1, posted June 9, 2023 |
| 2Q22 | $15.767 | +$0.039 | 50 MG | Inj iron dextran | v1, posted December 14, 2022 |
| 1Q22 | $15.728 | −$0.11 | 50 MG | Inj iron dextran | v1, posted June 8, 2022 |
| 4Q21 | $15.838 | +$0.049 | 50 MG | Inj iron dextran | v1, posted June 2, 2022 |
| 3Q21 | $15.789 | +$0.715 | 50 MG | Inj iron dextran | v1, posted June 2, 2022 |
| 2Q21 | $15.074 | +$0.02 | 50 MG | Inj iron dextran | v1, posted March 1, 2022 |
| 1Q21 | $15.054 | – | 50 MG | Inj iron dextran | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.